Épidémiologie; Biostatistique; Gestion des systèmes de santé; Communication pour la santé et sciences du comportement; Promotion de la santé; Écologie humaine; Informatique médicale; Économie de la santé ;
Médecine légale; Médecine du travail; Médecine préventive…

2014

1. Influence of migration on characteristics of type 2 diabetes in sub-Saharan Africans.
Choukem SP, Fabreguettes C, Akwo E, Porcher R, Nguewa JL, Bouche C, et al.
Diabetes Metab. 2014 Feb;40(1):56-60.  Lien

2013

1. Corrélâtes of cigarette smoking among university students in Cameroon.
Mbatchou Ngahane BH, Luma H, Mapoure YN, Fotso ZM, Afane Ze E.
Int J Tuberc Lung Dis. 2013 Feb;17(2):270-4. Lien

2. Hospital-based injury data from level III institution in Cameroon: retrospective analysis of the present registration system.
Chichom Mefire A, Etoundi Mballa GA, Azabji Kenfack M, Juillard C, Stevens K.
Injury. 2013 Jan;44(1):139-43. Lien

3. Impact of HIV comprehensive care and treatment on serostatus disclosure among Cameroonian patients in rural district hospitals. Suzan-Monti M, Kouanfack C, Boyer S, Blanche J, Bonono RC, Delaporte E, et al.Plosone: January 31, 2013. Lien

2012

1. Epidemiology of rotavirus diarrhea in children under 5 years in Northern Cameroon.
Ndze VN, Akum AE, Kamga GH, Enjema LE, Esona MD, Banyai K, et al.
Pan Afr Med J. 2012;11:73. Epub 2012 Apr 17 Lien

2. Implementation of HIV early infant diagnosis and HIV type 1 RNA viral load determination on dried blood spots in Cameroon: challenges and propositions.  Nkenfou CN, Lobé EE, Ouwe-Missi-Oukem-Boyer O, Sosso MS, Dambaya B, Gwom LC, et al.
AIDS Res Hum Retroviruses. 2012 Feb;28(2):176-81. Lien

3. Metabolic profile of sub-Saharan African patients presenting with first-ever-in-lifetime stroke: association with insulin resistance. Sobngwi E, Kengne AP, Balti EV, Fezeu L, Nouthe B, Djiogue S, Njamen D, Gautier JF, Unwin NC, Mbanya JC.  J Stroke Cerebrovasc Dis. 2012 Nov;21(8):639-46. Lien

4. Morbidité du paludisme dans les faciès camerounais : analyse des données de surveillance de 36 mois sur les groupes à risque. Nko’Ayissi G, Mbacham W, Massoda G. Médecine d’Afrique Noire 5909 – Août/sept. 2012 – pp 421-429. Lien

5. Multicentre study evaluating the non-inferiority of the new paediatric formulation of artesunate/amodiaquine versus artemether /lumefantrine for the management of uncomplicated Plasmodium falciparum malaria in children in Cameroon, Ivory Coast and Senegal.  Faye B, Kuété T, Kiki-Barro CP, Tine RC, Nkoa T, Ndiaye JL, et al.  Malar J. 2012 Dec 27;11:433. Lien

6. Screening for hyperglycemia in the developing world: rationale, challenges and opportunities. Echouffo-Tcheugui JB, Mayige M, Ogbera AO, Sobngwi E, Kengne AP. Diabetes Res Clin Pract. 2012 Nov;98(2):199-208. Lien

2011

1. The Cameroon mobile phone SMS (CAMPS) trial: a protocol for a randomized controlled trial of mobile phone text messaging versus usual care for improving adherence to highly active anti-retroviral therapy. Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills E, Volmink J, et al. Trials. 2011 Jan 7;12:5.  Lien

2. The impact of health education on the prevalence of faecal-orally transmitted parasitic infections among school children in a rural community in Cameroon. Fouamno Kamga HL, Shey Nsagha D, Suh Atanga MB, Longdoh Njunda A, Nguedia Assob JC, Nde Fon P, Akwi Fomumbod S. Pan Afr Med J. 2011;8:38. Epub 2011 Feb 4. Lien

3. Traditional medicine: past, present and future research and development prospects and integration in the National Health System of Cameroon. Fokunang CN, Ndikum V, Tabi OY, Jiofack RB, Ngameni B, Guedje NM, et al. Afr J Tradit Complement Altern Med. 2011;8(3):284-95. Lien